A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.

J Virol · 2021 · PMC8104102 · PMID 33568510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Nevertheless, integrative analysis of virological and immunological parameters showed a trend toward an association between good vaccine responders and a lower viral load after ATI, while individuals with poorer immunological responses (being vaccinated or not) exhibited a higher maximum viral load.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.